A study of neurobehavioral, clinical psychometric, and P3 changes in vitamin B12 deficiency neurological syndrome

Nutritional Neuroscience

Volumn 16, Issue 1, 2013, Pages 39-46

  Kalita, Jayantee ^a   Agarwal, Ritu ^a   Chandra, Satish ^a   Misra, Usha K ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

BVRT; Clock drawing; Dementia; Motor speed and precision test; NPI; P3; Subacute combined degeneration; Trail making test; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; HEMOGLOBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CLOCK DRAWING TEST; CYANOCOBALAMIN DEFICIENCY; EVOKED RESPONSE; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LATENT PERIOD; LURIA THREE STEP TEST; MALE; MEAN CORPUSCULAR VOLUME; MINI MENTAL STATE EXAMINATION; MOTOR SPEED AND PRECISION TEST; NEUROLOGIC DISEASE; NEUROPATHY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOMETRY; SCHOOL CHILD; SPINAL CORD DISEASE; VITAMIN B12 DEFICIENCY NEUROLOGICAL SYNDROME;

ADOLESCENT; ADULT; AGED; CHILD; COGNITION; COGNITION DISORDERS; EVENT-RELATED POTENTIALS, P300; FEMALE; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; QUESTIONNAIRES; VITAMIN B 12; VITAMIN B 12 DEFICIENCY; YOUNG ADULT;

EID: 84873143947     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/1476830512Y.0000000028     Document Type: Article

References (33)

1. Green R. Typical and atypical manifestations of pernicious anemia. In: Bhatt R, James VHT, Besser M, Bottasso F, Keen H (eds.) Advances in Thomas Addison's diseases, vol. 1. Bristol, UK: Journal of Endocrinology; 1994. p. 377-90.
2. Holmes JM. Cerebral manifestations of vitamin B12 deficiency. BMJ. 1956;2:394-1398.
3. McAlpine D. A review of the nervous and mental aspects of pernicious anaemia. Lancet. 1929;II:643-7.
4. Healton EB, Savage DG, Brust JCM, Garrett TJ, Lindenbaum J. Neurologic aspects of cobalamin deficiency. Medicine. 1991;70: 229-45
5. Kalita J, Misra UK. Vitamin B12 deficiency neurological syndromes: correlation of clinical, MRI and cognitive evoked potential. J Neurol. 2008;255:353-9.
6. Clarfield AM. The reversible dementias: do they reverse? Ann Intern Med. 1988;109:476-86.
7. Hector M, Burton JR. What are the psychiatric manifestations of vitamin B12 deficiency? J Am Geriatr Soc. 1988;36:1105-12.
8. Meadows ME, Kaplan RF, Bromfield EB. Cognitive recovery with vitamin B12 therapy: a longitudinal neuropsychiatric assessment. Neurology. 1994;44:1764-5.
9. O'Neill D, Barber RD. Reversible dementia caused by vitamin B12 deficiency. J Am Geriatr Soc. 1993;41:192-3.
10. Bell IR, Edman JS, Miller J, Hebben N, Linn RT, Ray D, et al. Relationship of normal serum vitamin B12 and folate levels to cognitive test performance in subtypes of geriatric major depression. J Geriatr Psychiatry Neurol. 1990;3:98-105.
11. De la Fourniere F, Piette F, Grandet P, Zittoun J. Value of vitamin B12 assay in presumed degenerative dementia. Presse Med. 1989;18:1664.
12. Moretti R, Torre P, Antonello RM, Cattaruzza T, Cazzato G, Bava A. Vitamin B12 and folate depletion in cognition: a review. Neurol India. 2004;52:310-8.
13. Sumi N, Naan'no H, Fjimoto O, Ohta Y, Takeda M. Interpeak latency of auditory event related potentials (P300) in senile depression and dementia of the Alzheimer type. Psychiatr Clin Neurosci. 2000;54:679-84.
14. Husstedt IW, Frohne L, Bockenhlt S, Frese A, Rahmann A, Heese C, et al. Impact of highly active antiretroviral therapy on cognitive processing in HIV infection: cross sectional and longitudinal studies of even related potential. AIDS Res Hum Retroviruses. 2002;18:485-90.
15. Kalita J, Misra UK, Srivastava A. Cognitive impairment in encephalitis: P3 and MRI correlation. Electromyogr Clin Neurophysiol. 2009;49:27-33.
16. Duncan CC, Barry RJ, Connolly JF, Fischer C, Michie PT, Näätänen R, et al. Event-related potentials in clinical research:-guidelines for eliciting, recording, and quantifying mismatch negativity, P300, and N400. Clin Neurophysiol. 2009;120: 1883-908.
17. Misra UK, Kalita J. Comparison of clinical and electrodiagnostic features in B12 deficiency neurological syndromes with and without antiparietal cell antibodies. Postgrad Med J. 2007;83:124-7.
18. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308-14.
19. Cummings JL. The neuropsychiatric inventory: assessing psychopathology in dementia patients. Neurology. 1997;48:S10-16.
20. Crum RM, Anthony JC, Bassett SS, Folstein MF. Populationbased norms for the mini-mental state examination by age and educational level. JAMA. 1993;269:2386-91.
21. Sunderland T, Hill JL, Mellow AM, Lawlor BA, Gundersheimer J, Newhouse PA, et al. Clock drawing in Alzheimer's disease: a novel measure of dementia severity. J Am Geriatr Soc. 1989; 37:725-9.
22. Misra UK, Kalita J, Kumar G, Kapoor R. Bladder dysfunction in subacute combined degeneration: a clinical, MRI and urodynamic study. J Neurol. 2008;255:1881-8.
23. Mendez MF, Ala T, Underwood KL. Development of scoring criteria for the clock drawing task in alzheimer disease. J Am Geriatr Soc. 1992;40:1095-9.
24. Mendez MF, Cummings JL. Dementia; a clinical approach. Philadelphia: Butterworth-Heinemann; 2003. p. 13-65.
25. Lees AJ, Smith E. Cognitive deficits in the early stages of Parkinson's disease. Brain. 1983;106:257-70.
26. Mayeux R, Stern Y, Rosen J, BensonF. 'subcortical dementia' a recognizable clinical entity? Ann Neurol. 1983;14:278-83.
27. Huber SJ, Shuttleworth EC, Paulson GW, Bellchambers MJ, Clapp LE. Cortical vs subcortical dementia. Neuropsychological differences. Arch Neurol. 1986;43:392-4.
28. Scalabrino G. Cobalamin (Vitamin B12) in subacute combined degeneration and beyond: traditional interpretation and novel theories. Experimetal Neurol. 2005;192:463-79.
29. Walker PR, Smith B, Carson C, LeBlank J, Skorska M, Woodhouse CS, et al. Induction of apoptosis in neoplastic cells by depletion of vitamin B12. Cell Death Differ. 1997;4:233-41.
30. Bledowski C, Prvulovic D, Hoechstetter K, Scherg M, Wibral M, Goebel R, et al. Localizing P300 generators in visual target and distractor processing: a combined event-related potential and functional magnetic resonance imaging study. J Neurosci. 2004;24:9353-60.
31. Martin DC, Francis J, Protetch J, Huff FJ. Time dependency of cognitive recovery with cobalamin replacement: report of a pilot study. J Am Geriatr Soc. 1992;40:168-72.
32. Vasconcelos OM, Poehm EH, McCarter RJ, Campbell WW, Quezado ZM. Potential outcome factors in subacute combined degeneration-review of observational studies. Gen Intern Med. 2006;21:1063-8.
33. Shevell MI, Rosenblatt DS. The neurology of cobalamin. Can J Neurol Sci. 1992;19:472-86.